Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company is headquartered in Rehovot, Israel.
52W High
$5.45
52W Low
$1.31
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.81
Valuation
Fair
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
15.55
EV/EBITDA (<8 favorable)
-5.97
EV/Revenue (<3 favorable)
10.90
P/S (TTM) (<3 favorable)
14.40
P/B (<3 favorable)
2.77
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
10.16%
Institutions (25–75% balanced)
12.23%
Shares Outstanding
12,716,000
Float
8,913,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
2,402,000
Gross Profit (TTM)
1,484,000
EPS (TTM)
-1.13
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-17.75%
ROE (TTM) (>15% strong)
-0.78%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.28
Momentum
Bearish momentumValue
0.0779
Previous
0.0898
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025